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The cobalt crust fungus Terana coerulea (Phanerochaetaceae family) was selected for a bio-guided study after an ethnobotanical survey at the Irati’s Forest 
(Navarra, Spain) for its local use as antibiotic. Six extracts of increasing polarity, from hexane to hot water, were obtained from powdered dry fungi and tested 
for cytotoxicity against four human tumour cell lines and one non-tumour primary cell culture. From the most cytotoxic, EtOAc extract, we isolated and 
identified three terphenyl neolignans: two of them new natural products, named corticins D and E, and one previously described as corticin A, whose earlier 
structure has been revised. Their structural elucidation and biological evaluation as cytotoxic agents are described. 
 




The cobalt crust fungus, Terana coerulea (Lam.) Kuntze (T. 
caerulea and formerly named Corticium caeruleum (Lam.) Fr.), 
belongs to the Phanerochaetaceae family and it is a saprotrophic 
fungus rare in Central and Western Europe but more commonly 
distributed in Southern Europe and subtropical and tropical regions. 
This species, easy to recognize by the indigo-blue colour of its 
hymeneal surface, is associated with all sorts of deciduous wood 
and on dead stems of big herbs [1]. No medicinal uses have been 
reported for this fungus, however an ethnobotanical study carried 
out by us with people from Irati’s Forest (Navarra, Spain), 
highlighted that it is locally used for its antibiotic properties, and 
this prompted us to perform the present work. Our investigation on 
this fungus led to the identification of three terphenyl neolignans, 
one of them previously described as corticin A, whose earlier 
proposed structure has been revised by us, and two new corticins. 
Here we describe their structural elucidation and biological 
evaluation as cytotoxic agents. 
 
Previous mycochemical investigations of T. coerulea cultures 
reported the isolation of secondary metabolites as the antibiotic 
cortalcerone, 1 [2], or the corticiolic acid, 2 [3] (Figure 1). 
Additionally, some blue or violet pigments were also obtained from 
the cultures of this fungus. They are structurally related with the 
violet lignanic metabolite thelephoric acid, 3, (Figure 1) or with 
polymerization products after their oxidation [4]. They are 
neolignans with a terphenyl structure that includes two oxygen 
bridges forming a benzo[1,2-b:4,5-b’]bisbenzofuranoid skeleton. 
These terphenyl metabolites are only biosynthesized by fungi and 
lichens [5]. Several derivatives of leuco-thelephoric acid (the p-
quinol form of thelephoric acid), methylated in any of its hydroxyl 
groups, have also been identified such as corticins A, 4, and B, 5 
[6], and the permethyl ether of leuco-thelephoric acid, 6 [7]. 
Corticins A and B, with three and four methyl groups respectively, 
were  isolated  as a  mixture by washing the  surface  of  the  fungus 
 
 
Figure 1: Thelephoric acid and compounds isolated from Terana coerulea 
cultures (formerly named as Corticium caeruleum). 
 
culture with cold chloroform [6]. Corticin C, 7, was another 
neolignan identified from the same culture and assigned to have a 
different benzo[1,2-b:5,4-b’]bisbenzofuranoid skeleton [6] (Figure 
1). These natural pigments were mainly characterized through some 
semisynthetic derivatives obtained from the mixtures of these 
neolignans, as the peracetylcorticins [8], or the peracetyl, permethyl 
or pertrimethylsilylderivatives of thelephoric acid [9]. Thelephoric 
acid is active in vitro against mouse leukemic cells P388 and its use 
as antitumor agent was patented [10]. 
 
In this work, six extracts of increasing polarity, from hexane to hot 
water, were obtained from powdered dry fungi and tested for 
cytotoxicity against four human tumour cell lines and one non-
tumour primary cell culture. The results are shown in Table 1. The 
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best cytotoxicity was observed for the EtOAc extract, followed by 
the CH2Cl2 extract; both of them were the most coloured ones (dark 
violet-blue-red). In fact, the EtOAc extract was the most potent 
against all human tumour cell lines, with GI50 values of 3 g/mL 
against breast adenocarcinoma MCF-7 or 6 g/mL against cervical 
carcinoma HeLa, and showing a lower cytotoxicity against non-
tumour porcine liver cells primary culture (PLP2) of 31 g/mL. 
These results prompted us to identify the components responsible 
for the activity. Thus, the column chromatography (CC) of the 
EtOAc extract on silica gel led to the isolation of the compound 8 





Figure 2: Structures of terphenyl neolignans 8-10 from the fungus Terana coerulea and 
preparation of the triacetylderivatives 11 and 12. 
 
Table 1: Cytotoxic activity of extracts and compounds obtained from the fungus 
Terana coerulea (GI50 ± SD, in g/mL). 
Sample HeLa NCI-H460 HepG2 MCF-7 PLP2
Hexane ext 73 ± 3 71 ± 3 77 ± 6 75 ± 3 157 ± 5 
CH2Cl2 ext 13 ± 2 20 ± 1 50 ± 4 15 ± 1 8.7 ± 0.8 
EtOAc ext 5.7 ± 0.5 12 ± 1 175 ± 8 3.2 ± 0.2 31 ± 3 
BuOH exta 55 ± 6 100 ± 8 341 ± 13 77 ± 5 > 400 
H2O ext
a 62 ± 2 215 ± 16 339 ± 25 93 ± 4 > 400 
Decoction 224 ± 14 > 400 > 400 279 ± 17 > 400 
8 20 ± 1 68.7 ± 0.6 43.4 ± 0.9 57 ± 4 128 ± 9 
8+9 (9:1) 14 ± 1 15 ± 1 20 ± 2 12.5 ± 0.9 59 ± 5 
8+9+10 (2:1:1) 19 ± 1 23.8 ± 0.1 35 ± 2 18.3 ± 0.6 84 ± 8 
Ellipticine 0.91 ± 0.04 1.03 ± 0.09 1.91 ± 0.06 1.1 ± 0.2 3.2 ± 0.7 
aBuOH and H2O soluble fractions from the MeOH extract. 
 
Compound 8 was obtained as a yellowish gum that turned black 
violet in presence of oxygen and light. Its molecular formula was 
determined to be C21H16O8 from the HRMS-ESI ion peak at m/z 
419.0726 [M+Na]+ (calcd 419.0737) and 1H and 13C NMR 
spectroscopic data. The 1H NMR spectrum (Table 2) indicated the 
presence of four singlet aromatic protons at  7.60, 7.52, 7.04 and 
7.01 ppm, and three methoxy groups at  4.34, 4.31 and 3.98 ppm. 
The 13C NMR spectrum confirmed the four aromatic methines at  
108.4, 105.5, 99.3 and 99.0 ppm, and the three oxygenated methyl 
groups at  61.2 (x 2C) and 57.2 ppm. Ten oxygenated aromatic 
quaternary carbons (between  134.5 and 152.7 ppm) and other four 
non-oxygenated ones (between  116.1 and 117.9 ppm) suggested a 
skeleton analogue to thelephoric acid [11] but in its p-quinol or 
leuco- form as occurs with corticin A described by Briggs et al. [6]. 
This structure was confirmed by two-dimensional NMR 
experiments performed in the present work and also by comparison 
with other natural products described in the literature as candidusins 
[12]. The chemical shifts found for the methoxy groups and their 
comparison with 4’’-deoxycandidusin A and 4,5-
dimethoxycandidusin A [12] confirmed that two of the three 
methoxy groups were the substituents at C-8 and C-8’. The HMBC 
correlations between these methoxy groups at  4.34 and 4.31 ppm 
with the two quaternary aromatic carbon signals at  134.5 ppm 
agree with the same p-dimethoxybenzenic ring present in 
candidusin derivatives. The HMBC correlations among the 
additional methoxy group ( 3.98 ppm), the H-3’ ( 7.04 ppm) and 
the H-6’ ( 7.60 ppm) signals with six aromatic carbons ( 152.7, 
148.4, 146.2, 117.4, 105.5 and 99.3 ppm) allowed us to place all 
these signals at the same aromatic ring and thus, the assignment of 
the rest of the signals in the spectra. Moreover, a definitive ROESY 
correlation between protons of the methoxy group at C-5’ and H-6’ 
( 3.98 and 7.60 ppm) confirmed unequivocally a new terphenyl 
neolignan structure for the compound 8, with the IUPAC systematic 
name according to Moss [13]: 5',8,8'-trimethoxy-2,9’:2’,9-diepoxy-
9,7'-ciclo-7,9’-neoligna-7(9’),8,7’-triene-4,4’,5-triol, and named as 
corticin D (Figure 2). Several of those representative correlations 
are shown in Figure 3. 
 
Table 2: 1H NMR (400 MHz, CD3OD) data of compounds 8-10 ( in ppm). 
Position 8 9 10
H-3 7.01 (1H, s) 6.99 (1H, s) 7.00 (2H, s) 
H-6 7.52 (1H, s) 7.51 (1H, s) 7.51 (2H, s) 
H-3’ 7.04 (1H, s) 7.19 (1H, s) 7.00 (2H, s) 
H-6’ 7.60 (1H, s) 7.51 (1H, s) 7.51 (2H, s) 
CH3O-4’  3.96 (3H, s)  
CH3O-5’ 3.98 (3H, s)   
CH3O-8 4.31 (3H, s) 4.30 (3H, s) 4.30 (6H, s) 




Figure 3: Key HMBC and ROESY correlations for the structure elucidation of 
compound 8. 
 
The next fractions from the CC of the EtOAc extract contained 
compound 8 with a minor analogue 9 in a 9:1 ratio. This mixture 8 
+ 9 showed only a pair of ions MS-ESI in both positive (m/z 397, 
[M+H]+) and negative (m/z 395, [M-H]-) ion modes that suggested 
isomeric structures for these compounds. The negative MS/MS 
investigation of ion m/z 395 detected for compound 9 lead to the 
fragments at m/z 380 and 365 due to the loss of a methyl group and 
formaldehyde respectively from the parent ion. The 1H NMR 
chemical shifts for compound 9 (Table 2), the residual signals in 13C 
NMR spectrum, the 2D-NMR experiments together with the 
comparison with substituted dibenzofurans described in literature 
[12] and with 8, led us to propose its isomeric structure 4',8,8'-
trimethoxy-2,9’:2’,9-diepoxy-9,7'-ciclo-7,9’-neoligna-7(9’),8,7’- 
triene-4,5,5’-triol for compound 9 (Figure 2). 
 
Our compounds 8 and 9, identified through the spectroscopic 
studies shown above, have three methoxy groups in their structures, 
the same number that corticin A has [6], so we wondered if any of 
our isolated terphenyl derivatives were or not different from corticin 
A. At the moment corticins were described first by Briggs et al. [6], 
they proposed the structure represented as 4 (Figure 1) for corticin 
A on the basis of its UV, IR and MS fragments of a mixture of 
corticins A and B and through the 1H NMR signals of the isolated 
triacetyl derivative. Thus, a mixture of 8 + 9, in a 3:1 ratio, was 
acetylated in order to compare with the triacetate described by 
them. The NMR data obtained for the triacetate 11, derived from 
the major component 8, did not coincide with any of those 
described in the literature, but the signals obtained for the triacetate 
12, derived from the minor component 9, were identical to those 
described by Briggs [6] for the corticin A triacetate (Table 3). 
Considering that the structure of 9 has been properly established in 
this work, it would be concluded that the earlier structure for 
corticin A (compound 4 in Figure 1) would be corrected to structure 
9 (Figure 2). 
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Table 3: 1H NMR (400 MHz, CDCl3) spectroscopic data of triacetylneolignans 11-12 
and corticin A triacetate from Briggs et al. [6] ( in ppm). 
Position 11 12 Corticin A triacetate [6]
H-3 7.29 (1H, s) 7.17 (1H, s) 7.16 (1H, s) 
H-6 7.73 (1H, s) 7.83 (1H, s) 7.83 (1H, s) 
H-3’ 7.42 (1H, s) 7.41 (1H, s) 7.42 (1H, s) 
H-6’ 7.96 (1H, s) 7.95 (1H, s) 7.96 (1H, s) 
CH3O-4’  3.92 (3H, s) 3.92 (3H, s) 
CH3O-5’ 3.96 (3H, s)   
CH3O-8/8’ 4.37 (3H, s) 4.35 (3H, s) 4.36 (3H, s) 
 4.35 (3H, s) 4.33 (3H, s) 4.34 (3H, s) 
CH3-COO- 2.34 (3H, s) 2.34 (3H, s) 2.35 (3H, s) 
 2.37 (6H, s) 2.35 (6H, s) 2.36 (6H, s) 
 2.37 (6H, s) 2.35 (6H, s) 2.36 (6H, s) 
 
A different terphenyl derivative 10 was detected in the more polar 
fractions. It showed only three singlets in the 1H NMR spectrum 
(Table 2) that indicated a symmetric structure with only two 
methoxy groups at C-8 and C-8’ and with the chemical shifts of the 
aromatic protons corresponding with two symmetric catechol 
moieties in both other aromatic rings. The [M−H]− ion for 10 was 
easily obtained (MS-ESI m/z 381), but the [M+H]+ ion could not be 
observed. Therefore, the MS/MS investigations for this compound 
was also in negative mode, observing the ions m/z 379 [M-H-H2]
-, 
366 [M-H-CH3]
- and 351 [M-H-CH2O]
-, which concludes in the 
assignment of a new neolignan structure, 8,8'-dimethoxy-2,9’:2’,9-
diepoxy-9,7'-ciclo-7,9’-neoligna-7(9’),8,7’-triene-4,4’,5,5’-tetraol, 
named as corticin E (Figure 2) for the compound 10 (Figure 2). 
 
The three compounds (8-10) present catechol moieties on their 
structures, which suggest that its aerial oxidation to 1,2-quinone 
could be the reason for its instability and the formation of blue-
violet pigments in the presence of oxygen and light. Particularly, 
corticin E (10), which has two catechol moieties, was a compound 
impossible to isolate alone. The yellow compound that went down 
through the CC in more polar fractions than those described in the 
experimental section, turned in a black dust as coal just in the drop 
that eluted from the column. This black dust could be the insoluble 
polymer described by Neveu et al. in the first studies with this 
fungus, in which they showed that fungal mycelia cultivated in the 
dark were white and only produced leuco-derivatives, which turned 
blue and decomposed when they were isolated in contact with the 
air [4]. 
 
The terphenyl derivatives were subjected to the same cytotoxicity 
assay as the extracts. As can be seen in Table 1, they were cytotoxic 
but the GI50 values observed for the compound 8 and the other 
mixtures of neolignans indicated somewhat less potency than the 
EtOAc extract itself. This could be due to the degradation that these 
compounds suffer under different conditions or even because they 
are not the only active ones in this extract, so, further chemical 
studies will be necessary to clarify it. 
 
Carefully analysis of the 1H NMR spectra (CDCl3 and CD3OD) of 
the second most potent extract, CH2Cl2 extract, showed, at least, the 
presence of the same neolignans 8 and 9 and a new set of signals 
that coincide with those described in the literature for corticiolic 
acid (2) [3]. These compounds could explain the bioactivity 
observed for this extract too (Table 1). 
 
In summary, the cobalt crust fungus Terana coerulea 
(Phanerochaetaceae family) was selected for a bio-guided study 
after an ethnobotanical survey at the Irati’s Forest (Navarra, Spain), 
where it is locally used for its antibiotic properties. Six extracts of 
increasing polarity, from hexane to hot water, were obtained from 
powdered dry fungi and tested for cytotoxicity against four human 
tumour cell lines and one non-tumour primary culture. CC of the 
most cytotoxic EtOAc extract led to the identification and structure 
elucidation of three terphenyl neolignans, which differ in the 
position and number of methoxy groups. One of them was 
previously described as corticin A, whose earlier structure has been 
revised in this work. The other two neolignans are new natural 
products, named corticins D and E. They were cytotoxic although 
less potent than the EtOAc extract itself, maybe due to possible 
degradations under different conditions or to the presence of other 
bioactive compounds, which merit further chemical investigations 




General: 1H and 13C NMR experiments were recorded on a Bruker 
Avance 400DRX (400 or 100 MHz, respectively) spectrometer in 
CD3OD or CDCl3 using the residual solvent signal as reference. 
Chemical shift () values are expressed in ppm followed by 
multiplicity. HRMS were run in a QSTAR XL Q-TOF (Applied 
Biosystems) using electrospray ionization (ESI) with an Agilent 
1100 HPLC. MS were obtained in a ZQ4000 (Waters) using ESI 
with a Waters Alliance 2795 HPLC. MS/MS analyses were 
recorded on an Agilent 1100 LC/MS Trap XCT using ESI. All 
reagents and solvents (analytical grade) were purchased from 
commercial sources and were used without further purification. 
Deionised water was purified using a Millipore Direct-Q (TGI 
Water Systems). Column chromatography purifications were 
performed using silica gel 60 (40-63 m, 230-400 mesh, Merck). 
 
Fungal Material: Dead branches of apple tree (Malus silvestris (L.) 
Mill.) with the fungus T. coerulea were collected in Irati’s Forest 
(Navarra, Spain) in 2016, 22nd February, at 750 m (42º58´35.78´´ N 
1º13´45.91´´ W). A voucher specimen was deposited at the 
Herbarium of the University of Salamanca (SALA-FUNGI 4195). 
The fungus was identified as Terana coerulea (Lam.) Kuntze [1]. 
 
Extraction: T. coerulea’s fruiting bodies were separated from its 
natural support (dead branches of apple tree) with a knife, air-dried 
and powdered with a mortar. 2.00 g were extracted successively at 
room temperature for 20 h with hexane (2 x 100 mL), CH2Cl2 (2 x 
100 mL), EtOAc (2 x 100 mL), MeOH (2 x 100 mL) and finally a 
decoction with hot water (100 mL). The evaporated MeOH extract 
was partitioned between water (100 mL) and n-BuOH (3 x 50 mL). 
Each organic extract was filtered and evaporated under reduced 
pressure, and aqueous extracts were lyophilized, to yield 24 mg of 
hexane extract (1.2% from dry weight of T. coerulea), 93 mg of 
CH2Cl2 extract (4.7%), 53 mg of EtOAc extract (2.7%), 107 mg of 
n-BuOH soluble fraction from the MeOH extract (5.4%), 18 mg of 
H2O soluble fraction from the MeOH extract (0.9%) and 75 mg of 
final aqueous decoction (3.8%). 
 
Isolation: The EtOAc extract (45 mg) was loaded on a silica gel 
column, eluted with a gradient of CH2Cl2/Me2CO (100:0–0:100, 
v/v) to afford 57 fractions. The sum of the fractions 9-10 (eluted 
with 97:3) led to the isolation of the 2.2 mg of compound 8 (0.11% 
from dry weight of T. coerulea). Fractions 11-14 (eluted with 97:3) 
gave 3.8 mg of a mixture of compounds 8 and 9 (9:1), fractions 15-
36 (eluted with 80:20 to 50:50) gave 7 mg of a mixture of 
neolignans 8 and 9 (3:1) and fractions 37-45 (eluted with 0:100) 
gave 3.8 mg of a mixture of compounds 8, 9 and 10 (2:1:1). 
 
Corticin D (8) 
Yellowish gum that turned black violet in presence of oxygen and 
light. 
1H NMR (400 MHz, CD3OD): Table 2. 
13C NMR (100 MHz, CD3OD): 57.2 (CH3O-5’), 61.2 (CH3O-8’), 
61.2 (CH3O-8), 99.0 (CH-3), 99.3 (CH-3´), 105.5 (CH-6´), 108.4 
(CH-6), 116.1 (C-7´), 116.1 (C-7), 117.4 (C-1´), 117.9 (C-1), 134.5 
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(C-8´), 134.5 (C-8), 143.3 (C-4), 143.7 (C-9´), 143.8 (C-9), 146.2 
(C-5´), 147.2 (C-5), 148.4 (C-4´), 152.2 (C-2), 152.7 (C-2´). 
HRMS-ESI: m/z [M + Na]+ calcd for C21H16O8Na: 419.0737; found: 
419.0726. 
 
Mixture of Corticins D (8), A (9) and E (10) 
Yellowish gum mixtures of compounds that turned black violet in 
presence of oxygen and light. 
 
Corticin A (9)  
1H NMR (400 MHz, CD3OD): Table 2. 
MS-ESI (positive): m/z 397 [M + H]+. 
MS-ESI (negative): m/z 395 [M – H]-. 




Corticin E (10) 
1H NMR (400 MHz, CD3OD): Table 2. 
MS-ESI (negative): m/z 381 [M – H]-. 






Acetylation of neolignans: A mixture of neolignans 8 and 9 (6 mg 
in proportion 3:1 from fraction 15-36) was acetylated with Ac2O 
(100 L) in pyridine (100 L) at room temperature for 12 h. The 
reaction was quenched with ice and extracted with EtOAc, washing 
the organic phase successively with aqueous solutions of HCl (2 N), 
NaHCO3 (satd.) and brine. After drying (anhydrous Na2SO4) and 
evaporating the solvent under vacuum, 7 mg of a mixture of 
compounds 11 and 12 (3:1) were obtained. 
 
Corticin D triacetate (11) 
1H NMR (400 MHz, CDCl3): Table 3. 
Corticin A triacetate (12) 
1H NMR (400 MHz, CDCl3): Table 3. 
 
Cytotoxicity assay: Compound 8 and mixtures of 8+9 and 8+9+10 
were evaluated against four human tumour cell lines: NCI-H460 
(non-small cell lung cancer), HeLa (cervical carcinoma), HepG2 
(hepatocellular carcinoma) and MCF-7 (breast adenocarcinoma) 
and against a non-tumour cell culture, designed as PLP2, prepared 
from a freshly harvested porcine liver according to an established 
procedure [14]. The corresponding cell line was plated at an 
appropriate density (1.0 × 104 cells/well) in 96-well plates and 
allowed to attach for 24 h. Cells were then treated for 48 h with the 
different diluted compound solutions. Afterwards, sulforhodamine 
B assay [15] was applied. The results were expressed as GI50 
values: sample concentration that inhibited 50% of the net cell 
growth. Ellipticine was used as positive control. For each 
compound, two independent experiments were performed, each one 
carried out in duplicate. Detailed procedure is described in the 
Supplementary material. 
 
Supplementary data: NMR and MS spectra relating to this article 
and detailed cytotoxicity assay are available. 
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